The Canadian Dental Association published a position paper in March 2026 supporting AI integration in clinical workflows, while stipulating that AI tools must function as decision-support aids — not autonomous diagnostic systems — and that final clinical decisions must always rest with the licensed practitioner. As of September 2026, this framework is shaping how Ontario practices adopt AI-powered imaging, charting, and patient communication tools.
As of September 2026, artificial intelligence is no longer a speculative technology in Canadian dentistry. AI-powered imaging analysis, automated clinical note generation, voice-activated charting, and intelligent scheduling systems are being deployed in practices across the Greater Toronto Area and beyond. The CDA's March 2026 position paper provides the first national-level framework for how Canadian dental professionals should integrate these tools responsibly.
What the CDA Position Paper Actually Says
The Canadian Dental Association's position paper, published in March 2026, establishes several principles that Canadian dental professionals must understand:
- AI as decision-support, not decision-maker: AI tools in dental practice must function as aids to clinical judgment. They may flag potential pathology on a radiograph, suggest treatment options, or identify patterns in patient data — but the treating dentist retains full authority over diagnosis and treatment planning.
- Practitioner liability unchanged: Using an AI diagnostic tool does not shift legal liability. The treating dentist remains responsible for all clinical decisions, regardless of whether AI was used in the assessment process. If an AI system misidentifies a lesion or overlooks pathology, the liability rests with the practitioner who relied on that output without adequate independent verification.
- Informed consent considerations: Practices using AI-assisted diagnostics should consider whether patients need to be informed that AI tools are being used as part of their care, particularly when AI outputs directly influence treatment recommendations.
Pro Tip: Ontario dentists should document their AI tool validation process in their practice quality assurance records. If the Royal College of Dental Surgeons of Ontario (RCDSO) peer assessment program audits your practice, demonstrating that you verified AI outputs against your own clinical judgment — rather than accepting them uncritically — strengthens your compliance position.
Canada's Dual-Track Regulatory Framework
Understanding how AI dental tools are regulated in Canada requires recognizing that two separate regulatory layers apply. Health Canada evaluates AI-based Software as a Medical Device (SaMD) through its Medical Device Regulations. Any AI tool that claims to detect, diagnose, or guide treatment of a medical condition requires a Medical Device Licence before it can be marketed in Canada.
Provincial regulatory bodies — the RCDSO in Ontario, the College of Dental Surgeons of British Columbia, the Alberta Dental Association and College, and their counterparts in other provinces — set practice-level guidelines for how licensed tools may be used in patient care. A tool that holds a Health Canada licence is legally marketable, but the provincial college determines whether and how it fits into the standard of care for that jurisdiction.
This dual-track system means that an AI imaging analysis tool cleared by the U.S. FDA is not automatically available in Canada. It must undergo Health Canada's own review process, which evaluates safety, efficacy, and the quality management system of the manufacturer. Canadian practices should never assume that a tool marketed in the United States has Canadian regulatory clearance.
How Ontario Practices Are Adopting AI in 2026
Across Ontario, dental AI adoption is accelerating in several distinct categories. Understanding these categories helps practice owners evaluate which investments align with their clinical and operational priorities.
AI-Powered Radiograph Analysis
The most visible category of dental AI involves software that analyzes periapical, bitewing, and panoramic radiographs to detect caries, periapical pathology, bone loss, and other findings. These tools overlay annotations on the radiograph to draw the clinician's attention to areas of concern. Several platforms with FDA clearance are available in the United States, and some have obtained Health Canada Medical Device Licences for use in Canadian practices.
The clinical value proposition is not that AI replaces the dentist's diagnostic eye, but that it serves as a consistent second reader. Studies have shown that even experienced clinicians miss a percentage of early interproximal caries on bitewing radiographs. An AI system that flags potential findings for the dentist to confirm or dismiss can reduce missed diagnoses — particularly in high-volume practices where fatigue is a factor.
Automated Clinical Documentation
AI-powered voice scribes and charting assistants are gaining traction in Ontario dental offices. These tools listen to the clinical conversation during an examination, extract relevant findings, and populate the electronic dental record with structured clinical notes. The appeal is time savings: manual charting consumes a significant portion of clinical time that could otherwise be spent on patient interaction or additional procedures.
The CDA's position paper is particularly relevant here. Automatically generated clinical notes must be reviewed and approved by the treating dentist before they become part of the patient's official record. An AI scribe that captures "watch lower-left six" and translates it into a clinical entry about tooth 36 needs verification that the tooth number, the finding, and the recommended follow-up are accurate.
Intelligent Scheduling and Patient Communication
AI agents handling front-desk functions — answering phones, booking appointments, sending recall reminders, and managing waitlists — represent the fastest-growing category of dental AI adoption in 2026. These systems operate outside the clinical decision-making framework addressed by the CDA position paper, since they do not diagnose or recommend treatment. However, they raise their own considerations around patient data privacy under the Personal Information Protection and Electronic Documents Act (PIPEDA) and provincial privacy legislation.
Pro Tip: Before deploying an AI phone or chat agent, confirm where patient conversation data is stored and processed. Under PIPEDA, personal health information must be handled with appropriate safeguards. If the AI vendor processes data outside Canada, your practice's privacy impact assessment should address cross-border data transfer risks.
What the RCDSO Has Signalled
The RCDSO has not yet published a standalone policy on AI use in Ontario dental practice. However, several existing RCDSO standards and guidelines apply by extension:
- Standard of Practice: Record Keeping: Clinical records must accurately reflect the dentist's findings, diagnoses, and treatment decisions. AI-generated entries do not exempt the practitioner from this obligation.
- Quality Assurance Program: The RCDSO's peer assessment process evaluates whether practitioners maintain competent, ethical practice. A dentist who defers clinical judgment entirely to an AI tool — without independent verification — may face scrutiny during a peer assessment.
- Informed Consent: RCDSO guidelines require that patients understand the basis for treatment recommendations. If AI-derived findings materially influence a treatment plan, transparency about that influence is consistent with the informed consent standard.
The RCDSO's 2026–2030 strategic plan consultation, which closed earlier this year, included questions about technology integration in dental practice. Ontario dentists should anticipate more specific guidance from the College in the coming years as AI adoption becomes more widespread.
Practical Guidance for Ontario Practice Owners
For practice owners in Toronto, Mississauga, Brampton, Markham, Vaughan, and across the GTA who are evaluating AI tools, the CDA's position paper suggests a pragmatic framework:
- Verify Canadian regulatory status. Confirm that any AI tool claiming diagnostic or clinical decision-support capabilities holds a Health Canada Medical Device Licence. FDA clearance alone is insufficient for legal marketing in Canada.
- Document your validation process. Maintain records showing that you independently verify AI outputs against your own clinical judgment. This is both good clinical practice and a defensible position during RCDSO peer assessment.
- Review vendor data handling. Ensure the AI vendor's data processing practices comply with PIPEDA and any applicable provincial privacy legislation. Ask specifically about data residency, encryption, access controls, and breach notification procedures.
- Train your team. Clinical staff interacting with AI tools must understand that AI outputs are suggestions, not directives. Build this principle into your practice's standard operating procedures and staff training documentation.
- Monitor regulatory developments. Both the CDA and RCDSO are likely to update their guidance as AI adoption accelerates. Subscribe to the CDA's publications and RCDSO bulletins to stay current.
Pro Tip: The CDA's position paper is available through the CDA website. Ontario dentists can also access RCDSO practice advisory guidance through the College's member portal. Both are valuable references for developing your practice's internal AI governance policy — a document that may soon become a de facto compliance expectation.
Frequently Asked Questions
Q: Does the CDA approve of dentists using AI to diagnose dental conditions in Canada?
The CDA supports AI integration as a decision-support aid, not as an autonomous diagnostic system. The March 2026 position paper makes clear that AI tools can flag potential findings and assist with analysis, but final clinical decisions must always rest with the licensed practitioner. The treating dentist retains full legal liability regardless of whether AI was used.
Q: Do Ontario dentists need to tell patients when AI is used in their diagnosis?
The CDA's position paper recommends that practices consider informing patients when AI tools directly influence treatment recommendations. While there is no specific RCDSO regulation mandating AI disclosure as of September 2026, existing informed consent standards in Ontario require that patients understand the basis for their treatment plan.
Q: Are FDA-cleared dental AI tools automatically approved for use in Canada?
No. Health Canada maintains its own regulatory framework for Software as a Medical Device. An AI tool cleared by the FDA must separately obtain a Health Canada Medical Device Licence before it can be legally marketed and sold in Canada. Canadian practices should always verify Health Canada licensing status independently.